Neuromuscular disorders in systemic malignancy and its treatment

Area of Science:

• Neurology
• Oncology
• Pathology

Background:

• Malignancy can cause neuromuscular dysfunction through direct tumor impact, remote paraneoplastic effects, or adverse reactions to cancer therapies like radiation and chemotherapy.
• This dysfunction can manifest at multiple anatomical levels, including neurons, nerve roots, plexuses, peripheral nerves, the neuromuscular junction, and muscles.

Purpose of the Study:

• To outline the primary etiologies of neuromuscular dysfunction in patients with cancer.
• To describe the diverse clinical syndromes resulting from cancer-related neuromuscular damage.
• To highlight the complexity arising from multifactorial and multi-site neurological involvement.

Main Methods:

• Review of established etiologies of neuromuscular dysfunction in oncology.
• Categorization of neurological damage based on anatomical sites affected (neuron, nerve root, plexus, peripheral nerve, neuromuscular junction, muscle).
• Analysis of clinical presentations arising from single or multiple causative factors and affected sites.

Main Results:

• Identified three main causes of neuromuscular dysfunction: direct neoplastic effects, paraneoplastic syndromes, and treatment side effects.
• Detailed the spectrum of neurological damage, affecting various components from the central nervous system to muscles.
• Emphasized that combined etiological factors and anatomical sites lead to complex clinical pictures.

Conclusions:

• Neuromuscular dysfunction in cancer patients is multifactorial, involving direct tumor effects, paraneoplastic phenomena, and treatment toxicity.
• Understanding the specific etiological pathways and anatomical targets is crucial for diagnosing and managing these complex neurological complications.
• The interplay of different causes and affected sites contributes significantly to the clinical heterogeneity observed in these patients.